Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level

OBJECTIVE: Inappropriate granulocyte colony-stimulating factor use with myelosuppressive chemotherapy has been reported. Using the Oncology Services Comprehensive Electronic Records electronic medical record database, prophylactic granulocyte colony-stimulating factor (pegfilgrastim/filgrastim) use...

Descripción completa

Detalles Bibliográficos
Autores principales: Baig, Hassam, Somlo, Barbara, Eisen, Melissa, Stryker, Scott, Bensink, Mark, Morrow, Phuong K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716357/
https://www.ncbi.nlm.nih.gov/pubmed/30200842
http://dx.doi.org/10.1177/1078155218799859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716357/
https://www.ncbi.nlm.nih.gov/pubmed/30200842
http://dx.doi.org/10.1177/1078155218799859

Ejemplares similares